Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroids for pneumonia in adults in Kenya
ISRCTN36138594Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Apr 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dexamethasone, betamethasone, hydrocortisone, methylprednisolone, prednisolone and 1 more in community-acquired pneumonia (CAP) (2 arms), sponsored by University of Oxford. Primary endpoint: 30-day mortality. Started Apr 2022; status: completed.
02
Drugs
dexamethasonebetamethasonehydrocortisonemethylprednisoloneprednisolone
03
Conditions
community-acquired pneumonia (CAP)
Beyond the preview
Go deeper on ISRCTN36138594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN36138594.